Battelle Memorial Institute
https://www.battelle.org/homepage
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Battelle Memorial Institute
FDA Approves First Next-Generation DNA Sequencing Platforms
Illumina’s MiSeqDx instrument and MiSeqDx Universal Kit, granted de novo approval, allow clinicians to “develop and validate sequencing of any part of a patient’s genome,” FDA says.
FDA Approves First Next-Generation DNA Sequencing Platforms
Illumina’s MiSeqDx instrument and MiSeqDx Universal Kit, granted de novo approval, allow clinicians to “develop and validate sequencing of any part of a patient’s genome,” FDA says.
News Briefs: Invacare Update; Patent Trolls; VC Trends
Invacare reports its earnings are hindered by an FDA consent decree, but management hopes to be released from the agreement soon. The American Hospital Association signs onto a letter to Congress calling for a crackdown on so-called “patent trolls.” More news in brief
Human Genome Research Led To $65 Billion In Economic Output In 2012, Says Battelle Report
A Battelle report on the impact of genomics on the U.S. economy found that research on human genome sequencing led to $65 billion in economic output in 2012, and contributed $31 billion toward the 2012 gross domestic product.
Company Information
- Industry
- Academic and Research Institutions
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice